Donald Woloszyn
Pulmonary Disease · Brunswick, MENPI 1437182862
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations.
Across 123 payments — averaging $28.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$844
- GSK$600
- Genentech USA, Inc.$476
- AstraZeneca$379
- Boehringer Ingelheim$255
- Regeneron Healthcare Solutions, Inc.$206
- plus $767 from 14 others
What the payments were for
- Food & beverage$3,45998%
- Education$682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $844 |
| GSK | 29 | $600 |
| Genentech USA, Inc. | 16 | $476 |
| AstraZeneca | 17 | $379 |
| Boehringer Ingelheim | 12 | $255 |
| Regeneron Healthcare Solutions, Inc. | 5 | $206 |
| Actelion Pharmaceuticals US, Inc. | 6 | $117 |
| Johnson & Johnson | 1 | $114 |
| Grifols USA, LLC | 6 | $110 |
| Novartis | 5 | $106 |
| Sanofi | 3 | $58 |
| Circassia Inc. | 3 | $52 |
| Shire North American Group Inc | 3 | $50 |
| Philips North America LLC | 2 | $39 |
| Merck | 2 | $32 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Electromed, Inc. | 2 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Synthroid$750
- DUPIXENT$125
- TRELEGY ELLIPTA$125
- INVOKANA$114
How this compares
$3,527 in reported general payments places this provider in the 85th percentile of 58 pulmonary disease providers in Maine.
Other pulmonary disease in Brunswick
- Hal SredenBrunswick$5K
- Alison WellsBrunswick$159
- Vu HoBrunswick$66
- James McCormickBrunswick$63
- Caitlin WelchBrunswick$38
- Patrick KeaneyBrunswick$15
- Jonathan EvansSouth Portland$322K
- Andrew FildermanRockport$210K
- Andrew DixonBangor$40K
- Meagan MooreSouth Portland$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.